Clinical trial
OptiLink HF Study (Optimization of Heart Failure Management Using Medtronic OptiVol® Fluid Status Monitoring and Medtronic CareLink® Network)
NCT00769457 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OptiLink HF Study (Optimization of Heart Failure Management Using Medtronic OptiVol® Fluid Status Monitoring and Medtronic CareLink® Network)
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- November 30, 2014
- Enrollment
- 1,002 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.